Oxidative damage has been reported in Rett syndrome (RTT), a pervasive development disorder mainly caused up to 95% of cases by mutations in the X-linked methyl-CpG binding protein 2 (MeCP2) gene. We have recently synthesized F2-Dihomo-isoprostanes (F2-Dihomo-IsoP), peroxidation products from adrenic acid (C22:4 n - 6, AdA), a known component of myelin, and tested the potential value of F2-Dihomo-IsoPs as a novel disease marker and its relationship with clinical presentation, and disease progression. F2-Dihomo-IsoPs were determined by a gas chromatography/negative ion chemical ionization tandem mass spectrometry. The ent-7(RS)-F 2t-Dihomo-IsoP and 17-F2t-Dihomo-IsoP were used as reference standards. The measured ions were the product ions at m/z 327 derived from the [M - 181]- precursor ions (m/z 597) produced from both the derivatized ent-7(RS)-F2t-Dihomo-IsoP and 17-F2t-Dihomo- IsoP. Average plasma F2-Dihomo-IsoP levels in RTT were about 1 order of magnitude higher than in healthy controls, being higher in typical RTT as compared to RTT variants, with a remarkable increase of about 2 orders of magnitude in patients at the earliest stage of the disease followed by a steady decrease during the natural clinical progression. These data indicate for the first time that quantification of F2-Dihomo-IsoPs in plasma represents an early marker of the disease and may provide a better understanding of the pathogenic mechanisms behind the neurological regression in patients with RTT. © 2012 Elsevier Masson SAS. All rights reserved.

Durand, T., De Felice, C., Signorini, C., Oger, C., Bultel-Poncé, V., Guy, A., et al. (2013). F(2)-Dihomo-isoprostanes and Rett syndrome. BIOCHIMIE, 95(1), 86-90 [10.1016/j.biochi.2012.09.017].

F(2)-Dihomo-isoprostanes and Rett syndrome

Signorini, C.;Leoncini, S.;Ciccoli, L.;Pecorelli, A.;
2013-01-01

Abstract

Oxidative damage has been reported in Rett syndrome (RTT), a pervasive development disorder mainly caused up to 95% of cases by mutations in the X-linked methyl-CpG binding protein 2 (MeCP2) gene. We have recently synthesized F2-Dihomo-isoprostanes (F2-Dihomo-IsoP), peroxidation products from adrenic acid (C22:4 n - 6, AdA), a known component of myelin, and tested the potential value of F2-Dihomo-IsoPs as a novel disease marker and its relationship with clinical presentation, and disease progression. F2-Dihomo-IsoPs were determined by a gas chromatography/negative ion chemical ionization tandem mass spectrometry. The ent-7(RS)-F 2t-Dihomo-IsoP and 17-F2t-Dihomo-IsoP were used as reference standards. The measured ions were the product ions at m/z 327 derived from the [M - 181]- precursor ions (m/z 597) produced from both the derivatized ent-7(RS)-F2t-Dihomo-IsoP and 17-F2t-Dihomo- IsoP. Average plasma F2-Dihomo-IsoP levels in RTT were about 1 order of magnitude higher than in healthy controls, being higher in typical RTT as compared to RTT variants, with a remarkable increase of about 2 orders of magnitude in patients at the earliest stage of the disease followed by a steady decrease during the natural clinical progression. These data indicate for the first time that quantification of F2-Dihomo-IsoPs in plasma represents an early marker of the disease and may provide a better understanding of the pathogenic mechanisms behind the neurological regression in patients with RTT. © 2012 Elsevier Masson SAS. All rights reserved.
Durand, T., De Felice, C., Signorini, C., Oger, C., Bultel-Poncé, V., Guy, A., et al. (2013). F(2)-Dihomo-isoprostanes and Rett syndrome. BIOCHIMIE, 95(1), 86-90 [10.1016/j.biochi.2012.09.017].
File in questo prodotto:
File Dimensione Formato  
Biochimie 2013.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 323.69 kB
Formato Adobe PDF
323.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/40962